Using our hardware and software, data obtained by detectors is fed into a fast microcomputer. The software allows full rotation of the developed 3D images. The computer enhances the latent image in much the same manner that images from the Hubble Space Telescope are enhanced to provide sharper, clearer images of the object in view. Preliminary tests of this technology indicate that the accuracy of the data images produced could surpass existing MRI and CT scanning technologies by as much as 20 to 30 times in detail and accuracy and provide image development in real-time, significantly reducing diagnostic errors. Our technology combines a precision, real-time imaging system with low dosage radiation. The imaging system provides real-time feedback for precision control of treatment procedures and real-time 3-D image reconstruction.
Micro LDRITM offers not only early detection, but also precision in the location of tumors. It provides the ability to monitor effectiveness as treatments are being applied. When combined, hyperthermia and chemical therapies are an effective alternative to surgical treatment.Traditional hyperthermia technology is unable to achieve the precise temperature control required in hyperthermia treatment to avoid damage to healthy tissue, and has thus been restricted by the Food and Drug Administration (FDA) since 1989. The technology used in Micro LDRITM ensures that treatment temperatures are high enough to be effective, but not so high that they cause damage to healthy tissues. Micro LDRITM will resurrect and enhance this proven therapy.
Saving LivesThis improvement in accuracy will allow for the safer diagnosis and treatment of tumors less than 0.5mm in diameter, whereas CT and MRI technology can only detect much larger tumors. For many patients, by the time traditional methods are able to identify malignant tumors, the disease has progressed to such a late stage that all a physician can offer is a prognosis of how many years the patient may have before they pass away. Diagnosing a tumor as small as 0.5mm means that a cancer may be diagnosed and treated from 7 to 12 years sooner. This increase in successful treatment of soft tissue tumors offers the opportunity for elimination of the cancer before it can metastasize. Micro LDRI permits more frequent and therefore more effective preventative checks for tumors. If tumors are found, treatment can start in the very early stages due to the low level radiation used by this system. In addition, this technology significantly reduces the risks typical of conventional higher-radiation methods. Using technology developed for the Strategic Defense Initiative (“Star Wars”), Micro LDRI utilizes near-field antennae and an energy control system. This provides precise targeting of hyperthermia therapy in conjunction with metabolism monitoring. This real-time metabolism monitoring and temperature feedback information allows heat treatment real-time adaptation and reduces the risk of tissue damage, a concern which has significantly restricted the possibility of hyperthermia treatments in the past.
“Micro LDRI™ offers doctors the ability to eradicate tumors completely non-invasively, thus eliminating the process of repetitive surgeries which many patients currently undergo.” When combined, hyperthermia and chemical therapies are an effective alternative to surgical treatment.Development
Our initial development has been very promising. Bench-testing of devices that use the new technology and software shows that we will be able to deliver a product with capabilities far beyond any of today’s tools. With ongoing research, we will continually be improving its effectiveness. Our technology, algorithms and software have patent protection. We believe that this portable and groundbreaking technology will have applications in all fields of oncology. We also anticipate that many other new methods of cancer diagnostics and treatment based on Micro LDRI™ will be developed in the future.
It may also spur the development of many new methods of treatment which require the online, real-time monitoring of metabolic responses to radiation, chemotherapy, and other treatments that can be achieved with Micro LDRI™. While the development and delivery of this product has vast commercial potential, it is most exciting in its potential to revolutionize treatment of some of the most deadly forms of cancer.